Home › NDC Lookup › RxCUI directory › RxCUI 1731582

1 ML glycopyrrolate 0.2 MG/ML Injection — RxCUI 1731582

RxNorm drug concept · Semantic clinical drug
RxCUI 1731582 Semantic clinical drug · SCD ● Current RxNorm concept 100 FDA products 110 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1731582
Official name1 ML glycopyrrolate 0.2 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asglycopyrrolate 0.2 MG per 1 ML Injection; glycopyrrolate 0.2 MG in 1 ML Injection
FDA products mapped100
Package NDCs mapped110
Reported Medicaid activity (SDUD)44,992 prescriptions · 42 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Glycopyrronium Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Qbrexza is a medicated cloth you wipe under your arms once a day. It contains glycopyrronium, which blocks the signal your nerves send to your sweat glands. The result is that your...
  • What exactly is Qbrexza and what is it supposed to do?
  • Each pouch holds one pre-moistened cloth. Tear it open, unfold the cloth, and wipe it across one underarm once — then use that same cloth on your other underarm. Apply it to clean,...
  • Dry mouth is the most common one — about 1 in 4 people in trials noticed it. You might also experience blurred vision, dilated pupils, mild difficulty urinating, headache, or dryne...
📖 Read our full Glycopyrronium Topical guide →

🕸️ Concept Web — How 1 ML glycopyrrolate 0.2 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 1 ML glycopyrrolate 0.2 MG/ML Injection RxCUI 1731582

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Glycopyrronium 1546438
    • Glycopyrrolate 4955
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Glyrx 2371711
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Glycopyrronium Injection 1731581
    • Glycopyrrolate Injection 2646688
    • Glycopyrronium Injectable Product 2109869
    • Glycopyrrolate Injectable Product 2661860
    • Glycopyrronium Injection [Glyrx] 2371717
    • Glycopyrrolate Injection [Glyrx] 2655471
    • Glyrx Injectable Product 2371714
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Glycopyrrolate 0.2 MG/ML SCDC · 315999
  • Glycopyrronium Injection SCDF · 1731581
  • Glycopyrrolate Injection SCDFP · 2646688
  • Glycopyrronium Injectable Product SCDG · 2109869
  • Glycopyrrolate Injectable Product SCDGP · 2661860

Brand-Name Concepts

  • 1 ML glycopyrrolate 0.2 MG/ML Injection [Glyrx] SBD · 2371718
  • Glycopyrrolate 0.2 MG/ML [Glyrx] SBDC · 2371712
  • Glycopyrronium Injection [Glyrx] SBDF · 2371717
  • Glycopyrrolate Injection [Glyrx] SBDFP · 2655471
  • Glyrx Injectable Product SBDG · 2371714
  • Glyrx BN · 2371711

📦 FDA Products & Package NDCs

100 products · 110 package NDCs
110 package NDCs map to RxCUI 1731582 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
71872-7208-01 1 VIAL, SINGLE-DOSE in 1 BAG (71872-7208-1) / 1 mL in 1 VIA... GLYCOPYRROLATE Medical Purchasing Solutions, LLC 2020-03-30
71872-7224-01 1 VIAL in 1 BAG (71872-7224-1) / 1 mL in 1 VIAL Glycopyrrolate Medical Purchasing Solutions, LLC 2020-09-17
71872-7238-01 1 VIAL, SINGLE-DOSE in 1 BAG (71872-7238-1) / 1 mL in 1 VIA... Glycopyrrolate Medical Purchasing Solutions, LLC 2021-01-28
72572-0225-25 25 VIAL, SINGLE-DOSE in 1 CARTON (72572-225-25) / 1 mL in 1... Glycopyrrolate Civica, Inc. 2019-12-10
72572-0226-25 25 VIAL, SINGLE-DOSE in 1 TRAY (72572-226-25) / 1 mL in 1 V... Glycopyrrolate Civica, Inc. 2021-01-31
75834-0193-25 25 VIAL, SINGLE-DOSE in 1 CARTON (75834-193-25) / 1 mL in 1... GLYCOPYRROLATE Nivagen Pharmaceuticals, Inc. 2021-10-25
75834-0194-25 25 VIAL, SINGLE-DOSE in 1 CARTON (75834-194-25) / 2 mL in 1... GLYCOPYRROLATE Nivagen Pharmaceuticals, Inc. 2021-10-25
75834-0195-25 25 VIAL, MULTI-DOSE in 1 CARTON (75834-195-25) / 5 mL in 1... GLYCOPYRROLATE Nivagen Pharmaceuticals, Inc. 2021-10-25
75834-0196-10 10 VIAL, MULTI-DOSE in 1 CARTON (75834-196-10) / 20 mL in 1... GLYCOPYRROLATE Nivagen Pharmaceuticals, Inc. 2021-10-25
84549-0543-25 1 mL in 1 VIAL, SINGLE-DOSE (84549-543-25) GLYCOPYRROLATE ProPharma Distribution 2025-09-15
Observed labelers: Hikma Pharmaceuticals USA Inc. (8) · Meitheal Pharmaceuticals Inc. (8) · Somerset Therapeutics, LLC (8) · Fresenius Kabi USA, LLC (6) · Medical Purchasing Solutions, LLC (6) · Xiromed LLC (5) · +20 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J1596 Inj, glycopyrrolate, 0.1 mg 57 CMS
J1597 Inj glycopyrrolate, glyrx-pf 2 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.